Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effects of Transcranial Pulse Stimulation in Parkinson's Disease

NCT: NCT06676995 · COMPLETED

NCT IDNCT06676995
StatusCOMPLETED
Start Date2024-12-31
Completion2025-07-30
SponsorSpaulding Rehabilitation Hospital (OTHER)
First posted
Last updated

Brief Summary

The investigators are studying if Transcranial Pulse Stimulation (TPS) can improve various symptoms, including movement problems, thinking abilities, mood, fatigue, freezing while walking, voice quality, and issues with smell and taste. Previous research suggests TPS might help in Alzheimer's disease and could be helpful for Parkinson's as well. Investigators will check if TPS is safe, practical, and if it makes a noticeable difference in these symptoms compared to before the treatment.

Frequently Asked Questions

What is Effects of Transcranial Pulse Stimulation in Parkinson's Disease?

Effects of Transcranial Pulse Stimulation in Parkinson's Disease is a clinical trial registered under NCT06676995. Current status: COMPLETED.

What is the status of NCT06676995?

The current status of NCT06676995 (Effects of Transcranial Pulse Stimulation in Parkinson's Disease) is: COMPLETED.

When did Effects of Transcranial Pulse Stimulation in Parkinson's Disease start?

Effects of Transcranial Pulse Stimulation in Parkinson's Disease started on 2024-12-31.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.